Buy Or Sell Opportunity • Jun 22
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 35% to ₩24,450. The fair value is estimated to be ₩30,801, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 12%. Buy Or Sell Opportunity • Mar 24
Now 22% overvalued Over the last 90 days, the stock has fallen 24% to ₩37,700. The fair value is estimated to be ₩30,801, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 15%. 공고 • Feb 13
Fursys Inc., Annual General Meeting, Mar 27, 2026 Fursys Inc., Annual General Meeting, Mar 27, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 311, ogeum-ro, songpa-gu, seoul South Korea Upcoming Dividend • Dec 22
Upcoming dividend of ₩1,200 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 10 April 2026. Payout ratio is a comfortable 30% but the company is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (3.4%). Reported Earnings • Nov 20
Third quarter 2025 earnings released: EPS: ₩1,520 (vs ₩539 in 3Q 2024) Third quarter 2025 results: EPS: ₩1,520 (up from ₩539 in 3Q 2024). Revenue: ₩80.1b (down 14% from 3Q 2024). Net income: ₩13.6b (up 182% from 3Q 2024). Profit margin: 17% (up from 5.2% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 16% per year. Declared Dividend • Nov 08
Dividend of ₩1,200 announced Dividend of ₩1,200 is the same as last year. Ex-date: 29th December 2025 Payment date: 10th April 2026 Dividend yield will be 2.7%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by earnings (41% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 2.2% per year over the past 4 years and payments have been stable during that time. The company's earnings per share (EPS) would need to decline by 55% to shift the payout ratio to a potentially unsustainable range, which is more than the 9.7% EPS decline seen over the last 5 years. 공고 • Nov 07
Fursys Inc. announces Annual dividend, payable on April 10, 2026 Fursys Inc. announced Annual dividend of KRW 1200.0000 per share payable on April 10, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. Board Change • Sep 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. New Risk • Aug 30
New minor risk - Financial data availability Less than 3 years of financial data is available. This is considered a minor risk. If the company has been trading for less than 3 years, then it has not had the opportunity to establish a long-term track record. This makes it difficult for investors to assess the true growth potential, sustainability and resilience of the business under different economic conditions. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (39% accrual ratio). Minor Risks Less than 3 years of financial data is available. Paying a dividend despite having no free cash flows. Reported Earnings • Aug 20
Second quarter 2025 earnings released: EPS: ₩1,010 (vs ₩1,752 in 2Q 2024) Second quarter 2025 results: EPS: ₩1,010 (down from ₩1,752 in 2Q 2024). Revenue: ₩82.3b (down 4.2% from 2Q 2024). Net income: ₩9.04b (down 42% from 2Q 2024). Profit margin: 11% (down from 18% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 26
Full year 2024 earnings released: EPS: ₩5,333 (vs ₩7,470 in FY 2023) Full year 2024 results: EPS: ₩5,333 (down from ₩7,470 in FY 2023). Revenue: ₩385.7b (up 6.3% from FY 2023). Net income: ₩47.7b (down 29% from FY 2023). Profit margin: 12% (down from 18% in FY 2023). Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. 공고 • Feb 12
Fursys Inc., Annual General Meeting, Mar 28, 2025 Fursys Inc., Annual General Meeting, Mar 28, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 311, ogeum-ro, songpa-gu, seoul South Korea Upcoming Dividend • Dec 20
Upcoming dividend of ₩1,200 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 17 April 2025. Payout ratio is a comfortable 20% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (3.9%). Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩38,450, the stock trades at a trailing P/E ratio of 5.1x. Average trailing P/E is 13x in the Commercial Services industry in South Korea. Total returns to shareholders of 23% over the past three years. Valuation Update With 7 Day Price Move • Jun 03
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩46,550, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 14x in the Commercial Services industry in South Korea. Total returns to shareholders of 20% over the past three years. Upcoming Dividend • Dec 20
Upcoming dividend of ₩1,100 per share at 3.3% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 10 April 2024. Payout ratio is a comfortable 17% and this is well supported by cash flows. Trailing yield: 3.3%. Lower than top quartile of South Korean dividend payers (3.5%). In line with average of industry peers (3.0%). Board Change • May 23
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Upcoming Dividend • Dec 21
Upcoming dividend of ₩1,100 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 11 April 2023. Trailing yield: 3.6%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (3.2%). Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Upcoming Dividend • Dec 22
Inaugural dividend of ₩1,000 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 12 April 2022. The company is not currently making a profit and is not cash flow positive. This is the first dividend for Fursys since going public. The average dividend yield among industry peers is 3.1%. 공고 • Feb 11
Fursys Inc., Annual General Meeting, Mar 26, 2021 Fursys Inc., Annual General Meeting, Mar 26, 2021, at 10:00 Korea Standard Time. Is New 90 Day High Low • Dec 16
New 90-day high: ₩29,800 The company is up 5.0% from its price of ₩28,350 on 17 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Commercial Services industry, which is down 4.0% over the same period. Is New 90 Day High Low • Nov 24
New 90-day high: ₩29,700 The company is up 5.0% from its price of ₩28,400 on 27 August 2020. The South Korean market is up 9.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Commercial Services industry, which is down 7.0% over the same period. Is New 90 Day High Low • Oct 21
New 90-day high: ₩28,800 The company is up 1.0% from its price of ₩28,400 on 23 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Commercial Services industry, which is up 3.0% over the same period. 공고 • Jun 30
Kareroom Medical Equipment Co.,Ltd. (XKON:A327970) agreed to acquire All rights and Business Related to the Manufacture of Medical Electric Beds of Fursys Inc. for KRW 1 billion. Kareroom Medical Equipment Co.,Ltd. (XKON:A327970) agreed to acquire All rights and Business Related to the Manufacture of Medical Electric Beds of Fursys Inc. for KRW 1 billion on June 26, 2020. As part of the transaction, consideration will paid in cash and a down payment of KRW 100 million will paid on June 26, 2020, interim payment of KRW 700 will be paid on July 31, 2020 and KRW 200 million will be paid on December 31, 2020. The transaction is expected to close on December 31, 2020. Changchun Accounting Corporatio acted as accountant to Kareroom Medical Equipment Co.,Ltd.